Navigation Links
Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
Date:4/30/2009

Issuance of Canadian Patents 2,363,503 and 2,407,715 Strengthens Intellectual Property Position of Optherion's Novel Diagnostics for Age-Related Macular Degeneration

NEW HAVEN, Conn., April 30 /PRNewswire/ -- Optherion, Inc., a company developing novel molecular diagnostics and treatments for dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system, announced today that the Canadian Patent Office has granted patents 2,363,503 and 2,407,715.

The claims of the issued patents provide secure protection for diagnostic tests for determining the predisposition to AMD by screening for genetic modifications in several genes including complement factor H (CFH), complement factor B (CFB), complement factor 2 (C2) and complement factor 3 (C3) amongst others. Optherion has an exclusive worldwide license to these Canadian patent rights, the corresponding PCT patents and applications from the University of Iowa Research Foundation.

Colin J. Foster, Optherion's President and CEO, said: "The issuance of the Canadian patents is an important milestone in the development of our diagnostics business. With these and other patents pending, licensed from almost a dozen universities, we are well positioned to exclusively offer a range of predictive and prognostic diagnostic tests to healthcare professionals treating patients with AMD and other diseases of the alternative complement system. As we advance to commercialization, we will continue to develop and protect our intellectual property covering our novel products."

Optherion is developing a genetic test for AMD and is pursuing commercialization discussions with several providers within North American and international markets.

About Optherion:

Optherion, Inc. is a private, innovative biotechnology company that is developing protein therapeutics and mol
'/>"/>

SOURCE Optherion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... ORLEANS , May 22, 2013 ... for commercially-insured patients with Type 2 diabetes, while ... to improve health outcomes and can lead to ... presented at the International Society for Pharmacoeconomics and ... The two studies, sponsored by Valeritas, makers ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
(Date:5/22/2013)... 22, 2013  Flagship Ventures, a leading venture ... and sustainability, today announced the appointment of ... Partner. In this role, Mr. Bancel will provide ... In addition to working closely with companies ... as President and Chief Executive Officer of Moderna ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... Novel siRNA Structures Exhibit Stability and Activity in ... Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company focused on discovering ... Company has filed a patent application covering a ... siRNA molecule stability and,excellent penetration into the human ...
... Artificial, Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to ... ... -Initial Compounds Demonstrate Promising In Vitro Activity Against, Devastating ... 27 Upstream Biosciences,Inc. (OTC Bulletin Board: UPBS) today announced it ...
Cached Medicine Technology:Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 2Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 2Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 3Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 4Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 5Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 6Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases 7
(Date:5/22/2013)... US (PRWEB) May 22, 2013 Award ... , Read the press release here: http://bit.ly/13DkFfk ... DataSite® was named “Information Management Product/Service of the Year” ... in March at The Colony Hotel in Palm Beach, ... virtual data room (VDR) solution that optimizes ...
(Date:5/22/2013)... Utah (PRWEB) May 22, 2013 Registered Dietitian ... an article today on Tatalou.com sharing a recipe for making ... Your Own Healthy Energy Bars ,” takes a recipe modified ... few important twists. , “Every day it gets more and ... our bodies,” said Chevreau. “The size of the nutrition label ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ICE Safety ... Women of Influence Award in recognition for her outstanding ... took place on Thursday, May 2 at The Fairmont, ... humbling for the 5,000 people ICE Safety Solutions certifies ... recognize the four to nine lives saved per year ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... children who die each year awaiting an organ donation ... increasing numbers of children are receiving donor organs. ... donors expanded to include not just patients who,ve experienced ... of death." But it,s unclear how much that ...
(Date:5/22/2013)... URBANA - A University of Illinois researcher says that ... should be to encourage more people to participate in ... , According to Craig Gundersen, SNAP, formerly known as ... net program and with some additional improvements could be ... households. Gundersen is a U of I professor of ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3
... Expected for Western Drug Companies, According to a Report ... Resources, one of the world,s leading research and advisory ... the colorectal cancer drug market in China will ... in 2007 to $290 million in 2012. This growth ...
... Three Grand Prize Winners Will Meet Nick Jonas TARRYTOWN, N.Y., ... Jonas of the Jonas Brothers invite kids and teens with ... Contest" online for a chance to meet Nick in person. ... Care and Nick, who has type 1 diabetes and uses ...
... 13 Adam Kluger Public Relations ( www.adamklugerpr.com ) announced Monday that AKPR ... b alancecenters . ... the Brain Balance Program(R), a revolutionary new approach to help children with Autism, ... For more than ten years, Dr. Robert Melillo , author of ...
... With a Mission of Encouraging Families to Be Incredibly Active ... PARK RIDGE, Ill. April 13 Today, the nation,s egg ... providing 13,500 dyed eggs for the 2009 White ... years, the event brings together families to hunt for and ...
... DocuSyst hosts FileHold document management solution which gives customers the ability ... in software and equipment. , ... Middleton, RI (PRWEB) ... Medicine Inc. is an out patient physical therapy group that provides ...
... Priorities to Improve Health Outcomes and Reduce WasteST. LOUIS ... ESRX ), and WellPoint, Inc. (NYSE: ... a definitive agreement under which Express Scripts, one of ... America, will acquire WellPoint,s NextRx subsidiaries for $4.675 billion, ...
Cached Medicine News:Health News:Chinese Colorectal Cancer Drug Market Will More Than Double by 2012 2Health News:Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win 2Health News:Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win 3Health News:Brain Balance(TM) Centers Picks Adam Kluger Public Relations (AKPR) to Help Promote New Book and Atlanta Event to Raise Awareness About Revolutionary New Way to Treat Learning Disorders; Atlantic Recording Artist/Country Music Star Zac Brown and Dr. Rober 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 3Health News:Olympic Physical Therapy Clears Space and Reduces Clutter with Hosted Document Management Solution from DocuSyst 2Health News:Olympic Physical Therapy Clears Space and Reduces Clutter with Hosted Document Management Solution from DocuSyst 3Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 2Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 3Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 4Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 5Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 6Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 7Health News:Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion 8
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: